UAB Medicine’s Leadership Development Office (LDO) honored 33 graduates of the Emerging Leaders Series (ELS) fall 2025 Cohort 4 during a ceremony held on Thursday, Nov. 12. The cohort completed a multi-session program designed to strengthen leadership capability for emerging leaders across the enterprise.

For many, the story of cancer in recent decades has been one of progress. Survival rates have improved dramatically, new therapies hold incredible promise, and once-deadly diagnoses now come with hope.

Julienne Carstens, Ph.D., is pioneering new techniques to track tumors in four dimensions. Her lab’s spatiotemporal work could help doctors zero in on the best therapies for specific patients, pinpoint when and where cancer cells are most vulnerable to manipulation and identify any cells in the area that could assist in the kill.

UAB Medicine’s Leadership Development Office (LDO) celebrated ten distinguished faculty members from the seventh cohort of the LEading, Advancing, Developing (LEAD) at a graduation ceremony on Thursday, Oct. 23.

Bassel El-Rayes, M.D., professor in the division of Hematology and Oncology, has been named the latest recipient of the school’s Featured Discovery Award. This recognition celebrates significant research contributions made by faculty and highlights the impact of their scientific advancements.

Tumor therapy with immune checkpoint blockers may be improved by fine-tuning Gfi1 in CD8+ T cells.

Hereditary hemorrhagic telangiectasia (HHT), also known as Osler-Weber-Rendu syndrome, is a rare, but serious, genetic disorder that causes abnormal blood vessels to form throughout the body. These abnormal vessels bypass much smaller blood vessels, or capillaries, creating direct connections between arteries and veins known as arteriovenous malformations (AVMs).

Chronic illnesses don’t take Saturdays off, and neither does the team at the UAB O’Neal Comprehensive Cancer Center Infusion Clinic. After experiencing a staggering 44 percent increase in patient encounters since 2020, this 84-bay infusion clinic turned to a dedicated team of multidisciplinary clinicians to pioneer Saturday infusion services.

The UAB Mary Heersink Institute for Global Health proudly announces the fourth cohort of pilot grant awardees. Three innovative projects have received pilot funding to encourage collaboration between UAB investigators and international partners, tackling critical global health challenges. Award recipients were notified on April 22. Congratulations to the 2025 selected teams!

The UAB Medicine Leadership Development Office recently recognized eight individuals in its sixth cohort of Sharing Authentically to Inspire and Lead (SAIL). The spring 2025 graduates were honored at a ceremony on April 8.

UAB’s new Lunaphore COMET multiplex immunofluorescent platform can hyperplex up to 40 antibodies on a single pathology tissue sample.

Rui Lu, Ph.D., associate professor in the Department of Medicine, has been named the latest recipient of the school's Featured Discovery award. This recognition celebrates notable research contributions made by faculty and highlights the impact of their scientific advancements.

A 3D printer for prosthetics, navigation for patients on dialysis and a new electron microscope are three of the 11 projects to receive funding. The HSF-GEF faculty grants program is a way for UAB to support innovative ideas from its researchers and clinicians.

This transformative gift from Ted W. Love, M.D., and Joyce Y. Love will improve patient care for those with sickle cell disease on a local and international level.

The UAB Department of Microbiology and the Center for AIDS Research (CFAR) hosted the inaugural HIV Basic and Translational Research Symposium Wednesday, Oct. 23, 2024, at the UAB Hilton Hotel. The all-day event featured speakers from the university and Southern Research, time for discussion, and a poster session.  

Borderline-resectable pancreatic cancer (BRPC) accounts for nearly 20% of all pancreatic cancer cases diagnosed in the U.S. These tumors are often attached to nearby arteries or veins, making surgery difficult and risky.

One UAB expert says the roles of screenings, warning signs and a healthy lifestyle are all keys to cancer prevention.

See the powerful documentary “The Last Ecstatic Days” at UAB's ALys Stephens Center and hear about the cultural and spiritual considerations of dying from UAB caregivers and Aditi Sethi, M.D., with The Center for Conscious Living & Dying, with guest artist Manjari Sharma.

Mortgage lending discrimination in the 1930s is still geographically associated with inequities in colon cancer care today. Colon cancer often can be treated successfully if detected early.

Geographic information systems technology is being used to study mortgage decisions, drinking behavior, environmental injustice, and the link between redlining and colon cancer. All Blazers now have free access to ArcGIS software.

Sickle cell disease is the most common and clinically significant inherited blood disorder across the nation, and now there is an FDA-approved gene therapy to help those living with SCD.

The O’Neal Comprehensive Cancer Center at UAB is recruiting Alabama women who have never had breast cancer for the study, to test a personalized approach to breast cancer screening.

The Blazer Bridge Fund is intended to identify and assist in the development of promising ideas, discoveries, innovations and/or technologies from UAB faculty and staff that have commercial potential. 

An overabundance of mast cells, which are important components of the immune system and are produced in the bone marrow, can lead to a variety of health issues.

The DOM is delighted that Bassel El-Rayes, M.D., will serve as the next Director of the Division of Hematology and Oncology. He will also serve as the deputy director for the The O’Neal Comprehensive Cancer Center at UAB - effective March 1, 2022.

This year, the university recognizes 50 years of service by Jeanne Hutchison, Ph.D., and Ferdinand Urthaler, M.D., and 45 years of service by Robert Kim M.D., and Joseph Lovetto. In addition, 294 employees with 20 or more years and 904 with five, 10 and 15 years will honored for their longevity.